Peptide Reference
Medically Relevant Peptides in Omaha
Explore the peptides most commonly prescribed by physicians in Omaha and across the country. Each compound links to its full evidence profile and physician directory.
BPC-157 in Omaha
BPC-157 is a synthetic pentadecapeptide. See the TruthTides evidence library for graded study summaries, regulatory status, and citations.
Thymosin Alpha-1 in Omaha
Thymosin Alpha-1 is a naturally occurring thymic peptide. See the TruthTides evidence and regulatory libraries for graded study summaries, approval status, and citations.
Ipamorelin in Omaha
Ipamorelin is a selective growth hormone secretagogue. See the TruthTides evidence library for graded study summaries and citations.
CJC-1295 in Omaha
CJC-1295 is a synthetic GHRH analog. See the TruthTides evidence library for graded study summaries, pharmacokinetic data, and citations.
Semaglutide in Omaha
Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Clinical trials demonstrate significant reductions in body weight and cardiovascular risk markers. It works by enhancing insulin secretion, suppressing glucagon, and reducing appetite.
Tirzepatide in Omaha
Tirzepatide is a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes (Mounjaro) and weight management (Zepbound). It has shown superior weight loss outcomes compared to semaglutide in head-to-head trials. The dual-agonist mechanism provides enhanced metabolic benefits.
Tesamorelin in Omaha
Tesamorelin is an FDA-approved synthetic GHRH analog indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. It stimulates physiological growth hormone secretion and has demonstrated significant visceral adipose tissue reduction in clinical trials.
Sermorelin in Omaha
Sermorelin is a synthetic analog of the first 29 amino acids of GHRH, previously FDA-approved for growth hormone deficiency diagnosis and treatment. It stimulates natural GH production from the pituitary gland and is widely used in age-management protocols for its favorable safety profile.
PT-141 (Bremelanotide) in Omaha
PT-141 (Bremelanotide) is an FDA-approved melanocortin receptor agonist indicated for hypoactive sexual desire disorder in premenopausal women (Vyleesi). It acts on MC3 and MC4 receptors in the central nervous system to modulate sexual arousal. It is distinct from PDE5 inhibitors in its mechanism of action.
GHK-Cu in Omaha
GHK-Cu is a naturally occurring tripeptide-copper complex. See the TruthTides evidence library for graded study summaries and citations.
TB-500 (Thymosin Beta-4) in Omaha
TB-500 is a synthetic fragment of Thymosin Beta-4. See the TruthTides evidence library for graded study summaries and citations.
Selank in Omaha
Selank is a synthetic heptapeptide analog of tuftsin developed in Russia. Available human trial data is limited and largely Russian-language. See the TruthTides evidence library for graded study summaries and citations.
Semax in Omaha
Semax is a synthetic analog of ACTH(4-10), approved in Russia. It is not FDA-approved. See the TruthTides evidence and regulatory libraries for graded study summaries and citations.
MOTS-c in Omaha
MOTS-c is a mitochondria-derived peptide. See the TruthTides evidence library for graded study summaries and citations.
Epitalon in Omaha
Epitalon is a synthetic tetrapeptide derived from a pineal-gland peptide. Published research is largely preclinical from a single Russian research group; human RCT data is limited. See the TruthTides evidence library for graded study summaries and citations.
Dihexa in Omaha
Dihexa is a synthetic hexapeptide analog of angiotensin IV. See the TruthTides evidence library for graded study summaries and citations.
AOD-9604 in Omaha
AOD-9604 is a modified fragment (amino acids 177-191) of human growth hormone specifically designed for fat metabolism. It stimulates lipolysis and inhibits lipogenesis without the diabetogenic effects of full-length GH. It has been studied for obesity management and cartilage repair applications.
Oral Estradiol in Omaha
Oral Estradiol is an FDA-approved menopausal estrogen. See the TruthTides evidence and regulatory libraries for indications, trial data, and citations.
Transdermal Estradiol in Omaha
Transdermal Estradiol is an FDA-approved menopausal estrogen delivered by patch, gel, or spray. See the TruthTides evidence and regulatory libraries for indications, comparative data, and citations.
Estradiol Valerate in Omaha
Estradiol Valerate is an esterified estradiol used in oral and injectable hormone therapy. See the TruthTides evidence and regulatory libraries for indications and citations.
Conjugated Estrogens (CEE) in Omaha
Conjugated Equine Estrogens (Premarin) are FDA-approved for menopausal hormone therapy. See the TruthTides evidence and regulatory libraries for trial data and citations.
Estriol in Omaha
Estriol (E3) is a weak endogenous estrogen used in low-dose vaginal preparations. See the TruthTides evidence and regulatory libraries for indications, regional availability, and citations.
Micronized Progesterone in Omaha
Micronized Progesterone (Prometrium) is FDA-approved for endometrial protection in postmenopausal women receiving estrogen and for secondary amenorrhea. See the TruthTides evidence library for comparative data and citations.
Medroxyprogesterone Acetate (MPA) in Omaha
MPA (Provera) is a synthetic progestin used for endometrial protection in combined HRT and for secondary amenorrhea. See the TruthTides evidence library for trial data and citations.
Norethindrone Acetate (NETA) in Omaha
Norethindrone Acetate is a progestin used in combined oral and transdermal HRT regimens for endometrial protection. See the TruthTides evidence and regulatory libraries for indications and citations.
Dydrogesterone in Omaha
Dydrogesterone is a retroprogesterone used outside the US for endometrial protection in combined HRT. See the TruthTides evidence and regulatory libraries for comparative data and citations.
Levonorgestrel IUS in Omaha
The Levonorgestrel intrauterine system (Mirena) provides localized progestogen for endometrial protection in women using systemic estrogen. See the TruthTides evidence and regulatory libraries for indications and citations.
Tibolone in Omaha
Tibolone is a selective tissue estrogenic activity regulator (STEAR) used outside the US for menopausal symptoms. See the TruthTides evidence and regulatory libraries for indications and citations.
Ospemifene in Omaha
Ospemifene (Osphena) is an FDA-approved oral SERM for menopausal GSM symptoms. See the TruthTides evidence and regulatory libraries for indications and citations.
Vaginal Low-Dose Estradiol in Omaha
Low-dose vaginal estradiol (cream, tablet, ring) is FDA-approved for genitourinary syndrome of menopause. See the TruthTides evidence and regulatory libraries for guideline summaries and citations.
Prasterone Vaginal (Intrarosa) in Omaha
Prasterone (intravaginal DHEA) is FDA-approved for menopausal dyspareunia. See the TruthTides evidence and regulatory libraries for indications and citations.
Testosterone Cypionate/Enanthate (IM) in Omaha
Intramuscular Testosterone Cypionate and Enanthate are FDA-approved injectable androgens for male hypogonadism. See the TruthTides evidence and regulatory libraries for trial data and citations.
Testosterone Transdermal Gel in Omaha
Transdermal Testosterone Gel (AndroGel, Testim, Fortesta) is FDA-approved for male hypogonadism. See the TruthTides evidence and regulatory libraries for indications, transference precautions, and citations.
Transdermal Testosterone for Women in Omaha
Low-dose transdermal testosterone has been studied for postmenopausal HSDD. No female-specific product is FDA-approved. See the TruthTides evidence and regulatory libraries for guideline summaries and citations.
hCG (Human Chorionic Gonadotropin) in Omaha
Human Chorionic Gonadotropin (hCG) is an LH-mimetic gonadotropin. It is FDA-approved for selected endocrine and fertility indications. See the TruthTides evidence and regulatory libraries for indications and citations.
Larazotide Acetate in Omaha
Larazotide acetate is an investigational, non-FDA-approved oral octapeptide studied for intestinal permeability in celiac disease. See the TruthTides evidence library for trial summaries and citations.